SNCA and Parkinson disease: Scott et al. report that there are changes in B lymphocytes that are associated with progression in Parkinson’s disease including increased antibodies to fibrillar alpha-synuclein in prodromal disease, decreased B cells and a protective effect of regulatory B cells.